Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

David Chacko (NPI 1922167303)

Field	Value
Entity Type	Individual
Organization	David Chacko
Address	655 N Woodlawn
City	Wichita
State	KS
ZIP	67208
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	December 8, 2006

Payer Source	Total Paid
Medicare	$2M
Medicaid	$0

Key Findings

DAVID CHACKO is a long-tenured retina specialist with an NPI enumeration date of 2006-12-08, indicating roughly 20 years of Medicare participation. That tenure suggests an established practice footprint in Wichita, KS and sustained Medicare billing relationships over time.

This provider’s Medicare activity is the only payer presence in the record: lifetime Medicare revenue is $2M while there is no Medicaid billing on file, so the practice functions effectively as single-payer (Medicare)-driven at least in public payer reporting. This concentration means analyses of public reimbursement should focus on Medicare-coded services.

Revenue concentration is high: the precomputed top 3 Medicare codes by revenue account for 81.2% of the provider’s total Medicare revenue, indicating that a small set of services—principally high-cost intravitreal injections—dominate topline Medicare receipts. This level of concentration implies the practice’s financial performance is heavily dependent on those specific treatment lines.

Clinical and service-line mix points to a retina-focused procedural practice: J0178 (aflibercept) is the largest single revenue source at $1.2M (59.8% of Medicare revenue) and, together with 67028 (injection procedure) and J2777 (faricimab), comprises the bulk of activity. The combination of high-volume injection claims and diagnostic imaging codes (92134, 92250) is consistent with a retina clinic delivering frequent anti-VEGF/anti‑angiogenic injections plus follow-up imaging and office-based visits.

Competitive standing across national peers is mixed by code: for high-revenue drugs, J0178 ranks #659 of 3204 providers (79th percentile), signaling above-average national standing but not dominance; 67028 ranks #121 of 4255 providers (97th percentile), indicating notably higher-than-typical procedural volume compared with peers; J2777 sits at the 34th percentile (rank #1338 of 2039), a more modest position. These rank/percentile placements show the provider is a prominent injector of certain agents while being more typical for others.

There are notable statistical outliers in the drug/compound mix: J7999 (compounded drug) appears as an extreme outlier, ranking #7 of 1333 providers (100th percentile) and generating $96.5K (4.8% of Medicare revenue). That unusually high relative volume of J7999 billing is a distinct pattern compared with national peers and merits attention when profiling supply-chain or dispensing practices.

Visit-level E/M and diagnostic volumes are above typical for many codes: 99214 and 99213 are at the 94th and 98th percentiles respectively, and retinal imaging codes 92134 and 92250 are both at or above the 95th percentile. This suggests the practice packages substantial office-based evaluation and monitoring alongside injection therapy, supporting a high-throughput outpatient retina model.

Procedure mix includes lower-volume surgical/operative codes (for example, 67041 at $34.8K and 42 claims, ranked at the 90th percentile), indicating the provider performs select surgical retina procedures in addition to the dominant injection/clinic work. While surgery contributes less to total Medicare revenue, its presence broadens the service scope beyond strictly office-based injections and imaging.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

17 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,760	$680	$1.2M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,780	$90	$244.5K
J2777	Injection, faricimab‑svoa, 0.1 mg	6,480	$30	$187.9K
J7999	Compounded drug, not otherwise classified	2,480	$40	$96.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	680	$80	$56.6K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	840	$60	$47K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,740	$30	$45.3K
92250	Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,…	1,780	$20	$39.2K
67041	In this procedure, the provider removes scar tissue from the retinal membrane that obscures vision. He removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical…	40	$830	$34.8K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	210	$120	$24.1K

Showing 1–10 of 17

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kansas Distribution

David Chacko — 7 of 17 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kansas

Full comparison — all codes billed, vs. state median

17 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	15	30	1,770	$690	$1.3M
J2777	21	30	12,060	$30	$575.7K
67028	2	40	1,170	$90	$111.4K
J7999	1	10	170	$40	$27K
67041	1	10	20	$970	$21.4K
99214	255	4,310	120	$70	$16.4K
92235	8	30	60	$90	$12.3K
99213	97	4,330	90	$50	$8.7K
99215	1,206	1,350	40	$100	$8.4K
92134	19	410	50	$30	$6K

Showing 1–10 of 17

Related Providers

Other providers that share a Tax Identification Number (TIN) with David Chacko, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Dyer	KS	Ophthalmology Physician	$7.5M	$0
Bassam Mattar	KS	Hematology & Oncology Physician	$7.2M	$0
Pavan Reddy	KS	Hematology & Oncology Physician	$6.7M	$0
Grene Vision Group LLC	KS	Ophthalmology Physician	$0	$6.3M
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Thomas Finley	OK	Ophthalmology Physician	$4.8M	$0
Daniel Feiler	KS	Ophthalmology Physician	$4.8M	$0
Travis Koeneke	KS	Hematology & Oncology Physician	$4.4M	$0
Christopher Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Stephen Wiles	MO	Ophthalmology Physician	$4.4M	$0

Nearby Providers

Other providers in the same ZIP code as David Chacko, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ascension Medical Group Via Christi, PA	KS	Multi-Specialty Clinic/Center	$0	$21.2M
County Of Sedgwick	KS	Case Manager/Care Coordinator	$0	$15.5M
County Of Sedgwick	KS	Psychiatry Physician	$0	$5.9M
Great Plains Dental Group, LLC	KS	General Practice Dentistry	$0	$5.8M
Mental Health America Of South Central Kansas, Inc.	KS	Community/Behavioral Health Agency	$0	$5.7M
Kidspace Pediatric Dentistry,p.a	KS	Pediatric Dentistry	$0	$4.4M
Cerebral Palsy Research Foundation Of Kansas, Inc	KS	Non-emergency Medical Transport (VAN)	$0	$4.3M
Nassim Nabbout	KS	Hematology & Oncology Physician	$4.2M	$0
Phu Truong	KS	Hematology & Oncology Physician	$4.1M	$0
Grace Home Care, LLC	KS	Home Health Agency	$0	$4M

David Chacko — Billing Profile & Reimbursement Data

Sign up for David Chacko — Billing Profile & Reimbursement Data policy alerts

David Chacko — Billing Profile & Reimbursement Data

Sign up for David Chacko — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References